Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight offers a unique perspective by tracking critical data relating
to the pharmaceutical CRO/CMO marketplace. The data they garner, as well as
their overall approach, puts them in a leading position for market
research."
Jeff Reinke editorial director, Pharmaceutical Processing & Manufacturing.net  
BioProcess International Conference
September 16-20 Boston, MA |
 
AAIPharma Services Corp. Aptuit LLC Boehringer Ingelheim GmbH Cirrus Pharmaceuticals Dr. Reddy's Laboratories Ltd. DSM Pharmaceutical Products IriSys, Inc. Laxai Avanti Life Sciences Pvt. Ltd. Lonza Lupin Pharmaceuticals, Inc.
Catalent Pharma Solutions, Inc. is a provider of development solutions and advanced delivery technologies for the global pharmaceutical, biotechnology and consumer health industry. The company assists customers in bringing products and treatments to market through its offerings of advanced delivery technologies, diverse range of formulation, dose form, manufacturing expertise and intellectual property. The company categorizes its business as Development & Clinical Services, Softgel Technologies, Modified Release Technologies, and Medication Delivery Solutions, which includes the company’s Packaging Services and Sterile Technologies offerings.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
